Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-044083

Director sold 4,946 shares at $24.38 ($120,587)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

LIN SUE-JEAN · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-15 Sale : show line 1 in the form 10b5-1 −4,946 $24.38 $120,587 27,567 D
Open-market sales · 4,946 sh · avg $24.38 · $120,587
Loading xslF345X06/wk-form4_1781743626.xml…